Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FXRW0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,449
Award facts
- Contract value 100% obligated
- $9,448.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,448.89 by the Defense Logistics Agency on September 23, 2025, for the supply of TYMLOS 80 MCG Dose Pen Injector 1.56ML. This delivery order was issued without a set-aside designation and carries an ultimate completion date of September 24, 2025. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's extensive contract portfolio with the DLA demonstrates consistent performance across diverse pharmaceutical categories, ranging from specialty medications and oncology treatments to vaccines and auto-injectors. This delivery order for the injectable osteoporosis medication represents a routine procurement transaction under the broader IDC framework, supporting the agency's ongoing medical supply requirements for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FXRW0?
SPE2DB25FXRW0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FXRW0 worth?
The government has obligated $9,449 on SPE2DB25FXRW0.
Is contract SPE2DB25FXRW0 an order under another contract?
Yes. SPE2DB25FXRW0 is a delivery order under SPE2DB24D9131, an indefinite delivery contract.
Was contract SPE2DB25FXRW0 competed?
The extent of competition for SPE2DB25FXRW0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award